Risk of Diabetic Ketoacidosis after Initiation of an SGLT2 Inhibitor

N Engl J Med. 2017 Jun 8;376(23):2300-2302. doi: 10.1056/NEJMc1701990.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Diabetes Mellitus / drug therapy
  • Diabetic Ketoacidosis / chemically induced*
  • Dipeptidyl-Peptidase IV Inhibitors / adverse effects*
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Middle Aged
  • Propensity Score
  • Risk
  • Sodium-Glucose Transporter 2 Inhibitors*

Substances

  • Dipeptidyl-Peptidase IV Inhibitors
  • Hypoglycemic Agents
  • Sodium-Glucose Transporter 2 Inhibitors